Table 1.

Binding of heparin-induced thrombocytopenia (HIT) sera to PF4 variants

Patients with HIT WT P37N T38Q A39V L41VN47D NAP2
Sensitive (n = 5)  3.10 ± 0.56 0.60 ± 0.31  1.56 ± 1.08 2.51 ± 0.99 1.67 ± 1.22  1.52 ± 1.10* 0.34 ± 0.31 
 A405 <1.0  
Intermediate (n = 9) 3.41 ± 0.40  1.98 ± 0.34  2.42 ± 1.06 3.12 ± 0.70  1.94 ± 1.10  3.12 ± 1.18 0.61 ± 0.42  
 A405 ≥1.0 to <2.5 
Insensitive (n = 9)  3.66 ± 0.10  2.99 ± 0.40 3.45 ± 0.29 3.27 ± 1.12  1.91 ± 1.44 2.88 ± 1.10* 0.45 ± 0.38  
 A405 ≥2.5 
Total (n = 23)  3.44 ± 0.41  2.06 ± 0.98 2.64 ± 1.10  3.04 ± 0.97  1.87 ± 1.22 2.64 ± 1.27  0.48 ± 0.38 
Patients with HIT WT P37N T38Q A39V L41VN47D NAP2
Sensitive (n = 5)  3.10 ± 0.56 0.60 ± 0.31  1.56 ± 1.08 2.51 ± 0.99 1.67 ± 1.22  1.52 ± 1.10* 0.34 ± 0.31 
 A405 <1.0  
Intermediate (n = 9) 3.41 ± 0.40  1.98 ± 0.34  2.42 ± 1.06 3.12 ± 0.70  1.94 ± 1.10  3.12 ± 1.18 0.61 ± 0.42  
 A405 ≥1.0 to <2.5 
Insensitive (n = 9)  3.66 ± 0.10  2.99 ± 0.40 3.45 ± 0.29 3.27 ± 1.12  1.91 ± 1.44 2.88 ± 1.10* 0.45 ± 0.38  
 A405 ≥2.5 
Total (n = 23)  3.44 ± 0.41  2.06 ± 0.98 2.64 ± 1.10  3.04 ± 0.97  1.87 ± 1.22 2.64 ± 1.27  0.48 ± 0.38 

Binding studies of 23 HIT sera to PF4 variants complexed to heparin, each with an A405 to wild-type PF4/heparin of >2.5. Subgroups of patients were classified by reactivity to mutations involving the third domain of PF4. Sera losing reactivity to third-domain mutations with A405 <1.0 were defined as sensitive, those retaining activity with A405 >2.5 as insensitive, and those with A405 ≥1.0 to ≤2.5 as intermediate in reactivity. The mean ± 1 SD is shown.

*

P < .05;

P < .01.

Close Modal

or Create an Account

Close Modal
Close Modal